Merck Animal Health to acquire Elanco’s aqua business

Bolsters Merck Animal Health’s position in the aqua industry with comprehensive approach to ensure fish health, welfare and sustainability in aquaculture, conservation and fisheries

Dr. Jitendra Singh launches multi-disciplinary post-doctoral courses in Bio-Sciences

1,000 Ph.D. students will be enrolled in the next five years to drive innovation in the critical healthcare sector

Mandaviya inaugurates new headquarters of the National Dental Commission

Additionally, an MoU was signed between the Dental Council of India and Quality Council of India for the assessment and rating of undergraduate dental colleges

Unichem Laboratories posts Q3 FY24 consolidated PAT at Rs. 83.99 Cr

Unichem Laboratories has reported total income of Rs. 445.65 crores during the period ended December 31, 2023

Sun Pharma Advanced Research Company Q3 FY24 loss at Rs. 99.65 Cr

Sun Pharma Advanced Research Company has reported total income of Rs. 20.25 crores during the period ended December 31, 2023

Aurobindo Pharma’s Eugia US Manufacturing to sell business assets to Empower Clinic Services for US$ 52 million

RPG Life Sciences posts Q3 FY24 PAT at Rs. 26.46 Cr

RPG Life Sciences Limited has reported total income of Rs. 155.62 crores during the period ended December 31, 2023

TTK Healthcare posts Q3 FY24 PAT at Rs. 12.89 Cr

TTK Healthcare has reported total income of Rs. 199.75 crores during the period ended December 31, 2023

KIMS posts Q3 FY24 consolidated PAT at Rs. 71.84 Cr

KIMS has reported total income of Rs. 609.091 crores during the period ended December 31, 2023

Mandaviya inaugurates 24 health infrastructure facilities across AIIMS

Delivers keynote address at the 4th convocation of AIIMS Jodhpur

Abbott India posts Q3 FY24 PAT at Rs. 310.98 Cr

Abbott India has reported total income of Rs. 1492.75 crores during the period ended December 31, 2023

Thyrocare Technologies posts Q3 FY24 consolidated PAT at Rs. 15.35 Cr

Thyrocare Technologies has reported total income of Rs. 137.47 crores during the period ended December 31, 2023

Dr Lal Path Labs posts Q3 FY24 consolidated PAT at Rs. 81.3 Cr

Dr. Lal Path Labs has reported total income of Rs. 557.2 crores during the period ended December 31, 2023

GMM Pfaudler posts Q3 FY24 consolidated PAT at Rs. 31.72 Cr

GMM Pfaudler has reported total income of Rs. 848.28 crores during the period ended December 31, 2023

Max Healthcare Institute Ltd Q3 FY24 consolidated profit up at Rs. 289.34 Cr

Max Healthcare Institute has reported total income of Rs. 1380.99 crores during the period ended December 31, 2023

Dabur India posts Q3 FY24 consolidated PAT at Rs. 514.22 Cr

Dabur India has reported total income of Rs. 3382.43 crores during the period ended December 31, 2023

Vimta Labs posts Q3 FY24 consolidated PAT at Rs. 10.13 Cr

Vimta Labs has reported total income of Rs. 82.57 crores during the period ended December 31, 2023

Morepen Laboratories reports Q3 FY24 consolidated PAT at Rs. 31.99 Cr

Morepen Laboratories has reported total income of Rs. 448.62 crores during the period ended December 31, 2023

Mankind Pharma reports 55% YoY growth in PAT for Q3 FY24

Revenue from Operations stood at Rs. 2,607 crore, 25% YoY growth. Domestic revenue at Rs. 2,400 crore, 20% YoY growth and export revenue at Rs. 207 crore, 118% YoY growth

Zydus Lifesciences launches Rexigo

This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India